The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunome Inc shares valued at $999,986 were purchased by SIEGALL CLAY B on Dec 18 ’25. At $21.50 per share, SIEGALL CLAY B acquired 46,511 shares. The insider’s holdings grew to 853,247 shares worth approximately $17.02 million following the completion of this transaction.
Also, BIENAIME JEAN JACQUES purchased 5,000 shares, netting a total of over 46,900 in proceeds. Following the buying of shares at $9.38 each, the insider now holds 36,415 shares.
Before that, BIENAIME JEAN JACQUES had added 7,800 shares to its account. In a trade valued at $60,684, the Director bought Immunome Inc shares for $7.78 each. Upon closing the transaction, the insider’s holdings increased to 7,800 shares, worth approximately $0.63 million.
As published in their initiating research note from Truist on December 01, 2025, Immunome Inc [IMNM] has been a Buy and the price target has been revised to $36. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in late September. As of September 05, 2025, Craig Hallum has initiated its “Buy” rating for IMNM. Earlier on April 02, 2025, Lake Street initiated its rating. Their recommendation was “a Buy” for IMNM stock.
Analyzing IMNM Stock Performance
On last trading session, Immunome Inc [NASDAQ: IMNM] rose 0.86% to $19.95. The stock’s lowest price that day was $19.37, but it reached a high of $20.49 in the same session. During the last five days, there has been a surge of approximately 2.36%. Over the course of the year, Immunome Inc shares have jumped approximately 60.37%. Shares of the company reached a 52-week high of $25.30 on 12/15/25 and a 52-week low of $5.15 on 04/09/25.
Support And Resistance Levels for Immunome Inc (IMNM)
According to the 24-hour chart, there is a support level at 19.38, which, if violated, would cause prices to drop to 18.81. In the upper region, resistance lies at 20.51. The next price resistance is at 21.07. RSI (Relative Strength Index) is 53.95 on the 14-day chart, showing neutral technical sentiment.
Is Immunome Inc subject to short interest?
Stocks of Immunome Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.18 million shares to 15.27 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 15.09 million shares. A jump of 1.16% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 11.5 of the overall float, the days-to-cover ratio (short ratio) jumped to 11.5.
Which companies own the most shares of Immunome Inc (IMNM)?
In terms of Immunome Inc share price expectations, FactSet research, analysts set an average price target of 34.5 in the next 12 months, up nearly 74.42% from the previous closing price of $19.78. Analysts anticipate Immunome Inc stock to reach 40 by 2025, with the lowest price target being 26. In spite of this, 3 analysts ranked Immunome Inc stock as Buy at the end of 2025. On November 08, 2024, Stephens assigned a price target of “an Overweight” to the stock and initiated coverage with a $30.
